Pan-cancer analyses reveal multi-omic signatures and clinical implementations of the forkhead-box gene family.

Our findings may provide a better understanding of roles FOX genes played in the development of tumors, and help to offer new avenues for uncovering tumorigenesis and unprecedented therapeutic targets.